Clinical Trial Update: Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of thyroxine therapy in hypothyroid women with recurrent pregnancy loss has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism
• Pregnancy Loss
• Thyroid Diseases

Drugs mentioned

• thyroxine (thyroxine)

Snippet

Sponsor: Al-Kindy College of Medicine | Conditions: Recurrent Early Pregnancy Loss, Thyroid Diseases | Phase 3 | Status: COMPLETED